IDEXX Laboratories Files 8-K on Financials
Ticker: IDXX · Form: 8-K · Filed: Aug 6, 2024 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: IDXX
TL;DR
IDXX filed an 8-K on Aug 6th for financial updates.
AI Summary
On August 6, 2024, IDEXX Laboratories, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This filing indicates that IDEXX Laboratories is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor.
Risk Assessment
Risk Level: low — This is a routine SEC filing reporting on financial condition and results of operations, with no immediate negative or positive news indicated in the provided text.
Key Players & Entities
- IDEXX LABORATORIES, INC. (company) — Registrant
- August 6, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19271 (legal_document_id) — Commission File Number
- 01-0393723 (tax_id) — IRS Employer Identification No.
- One IDEXX Drive, Westbrook, Maine 04092 (address) — Address of principal executive offices
- 207.55 (phone_number) — Business phone number
FAQ
What specific financial information is being reported in this 8-K filing?
The provided excerpt indicates the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail specific financial figures.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is August 6, 2024.
What is the company's state of incorporation and commission file number?
The company is incorporated in Delaware and its commission file number is 000-19271.
Where are IDEXX Laboratories, Inc.'s principal executive offices located?
The principal executive offices are located at One IDEXX Drive, Westbrook, Maine 04092.
What is the IRS Employer Identification Number for IDEXX Laboratories, Inc.?
The IRS Employer Identification Number is 01-0393723.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-08-06 06:30:36
Key Financial Figures
- $0.10 — ange on whichregistered Common Stock, $0.10 par value per share IDXX NASDAQ Glo
Filing Documents
- tm2420913d1_8k.htm (8-K) — 35KB
- tm2420913d1_ex99-1.htm (EX-99.1) — 441KB
- tm2420913d1_8kimg001.jpg (GRAPHIC) — 8KB
- tm2420913d1_ex99-1sp1img001.jpg (GRAPHIC) — 7KB
- 0001104659-24-086074.txt ( ) — 710KB
- idxx-20240806.xsd (EX-101.SCH) — 3KB
- idxx-20240806_lab.xml (EX-101.LAB) — 33KB
- idxx-20240806_pre.xml (EX-101.PRE) — 22KB
- tm2420913d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 6, 2024, IDEXX Laboratories, Inc. (the "Company") announced its financial results for the quarter ended June 30, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed. Exhibit No. Description of Exhibit 99.1 Press Release entitled "IDEXX Laboratories Announces Second Quarter Results," issued by the Company on August 6, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEXX LABORATORIES, INC. Date: August 6, 2024 By: /s/ Brian P. McKeon Brian P. McKeon Executive Vice President, Chief Financial Officer and Treasurer 3